The president has said the law is unfair to U.S. businesses. But lawyers say weakening it could end up costing corporate ...

Food and drug companies have expressed optimism, but the new health secretary and his MAHA movement will likely make waves.

As the Q4 2024 pharma earnings period rolls on through the first month of President Donald Trump’s second term, executives ...

Pfizer faces revenue decline from patent expirations, profitability challenges, and bearish technicals. Learn why PFE stock ...

Jefferies analyst Akash Tewari increased the price target for Pfizer (NYSE:PFE) shares from $33.00 to $34.00, while ...

Investors are undervaluing promising drug candidates on the horizon for the two pharma giants, write Yale SOM’s Jeffrey ...

We ranked the 10 best commercials from the 2025 Super Bowl and found them online so you can judge them for yourself.

The UK Chancellor’s messaging at Davos recalled former Taoiseach Enda Kenny’s efforts to extol the recovery of the Irish ...

We recently published a list of Why Are These 10 Dividend Stocks Declining? In this article, we are going to take a look at ...